跳至主要内容
临床试验/NCT00888485
NCT00888485已完成不适用

Secondary Prevention in Uppsala Primary Health Care After Myocardial Infarction, Coronary Artery CABG and PCI. Secondary Prevention After CHD (SUPRIM).

Uppsala University0 个研究点目标入组 362 人开始时间: 1996年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
362
主要终点
Admission to hospital for recurrent CHD event

研究概览

简要总结

The purpose of this study is to determine the possible preventive effect of behavioural modification versus standard treatment after hospital discharge in CHD patients.

详细描述

According to a recent Cochrane report there is little evidence so far that psychological interventions affected total or cardiac mortality, but had a reduction in the number of non-fatal recurrent AMI and small effect on anxiety and depression.

The subjects were recruited among consecutive patients discharged from Uppsala University Hospital. Inclusion criteria were age 75 years or younger, discharged from the hospital after a myocardial infarction (AMI) or percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), living in the hospital primary catchment area, referred back to the general practitioner (GP) within one year after the hospital admission, not having previously participated in similar programs, being Swedish speaking, being willing to participate in the study, and accepting the random group allocation to be. All subjects fulfilling the inclusion criteria were informed about the study during the first outpatient visit to the hospital two weeks after discharge. During a visit to the cardiology outpatient department three months after discharge the informed subjects were formally invited to participate and verbal informed consent was obtained, standard requirement at the time. A written invitation letter to a baseline examination in the study was then mailed to the subjects and those who accepted the invitation were eventually included. The recruitment period lasted from may 1996 to august 2001 and the follow-up data collection was completed in 2008.

At the end of the recruitment period 812 consecutive patients had been considered for inclusion, of which 302 did not fulfill the inclusion criteria, and 148 subjects declined to participate, in most cases because of long distance from home to the hospital or lack of time. The remaining 362 subjects (71.0% of eligible cases), 85 (23%) women, 277 (77%) men gave informed consent to participation, of whom 185 (51.1%) had been admitted for an AMI, 122 (33.7%) for a CABG, and 55 (15.2%) for a PCI. Seventy-one AMI subjects had a PCI performed during the course of events and three had a CABG. At the time of the study more than 95% of the Swedish population in these age groups was Caucasians and about 90% were native Swedes.

The group allocation was based on the SAS "ranuni" function that provides random numbers with equal probability. The randomization procedure was based on pre-prepared sealed envelopes with a serial number on the outside and containing a paper sheet with the group allocation on the front side and a blinding print on the back to eliminate the possibility to read the group allocation sheet from the outside of the envelope. The envelopes were kept in sorted ascending serial number order in a safe. After inclusion of a subject the study monitor (the only person with access to the randomization envelopes and information) drew the next envelope in order and inserted the allocation paper sheet in the study protocol. Of those included, 192 were allocated to behavioral intervention and 170 to the reference group. The included subjects were informed about the group allocation after the baseline measurement.The subjects received an invitation letter for a first (baseline) examination and a first postal questionnaire. The procedure was repeated at the 6th, 12th, 18th and 24th month after baseline. The examination included anthropometry (height, weight and sagittal diameter), and blood pressure measurement, and blood sampling for blood lipids.

Information on marital status, educational level, smoking habits, job status (including retirement or on sick leave), social background and lifestyle factors was obtained by questionnaire.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
— 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Discharged from hospital with CHD
  • Age 75 years or less
  • Living in hospital catchment area
  • Able to understand Swedish
  • Willing to accept randomized group

排除标准

  • Psychiatric disease
  • Participated in similar study previously

结局指标

主要结局

Admission to hospital for recurrent CHD event

时间窗: 8 years

次要结局

  • Quality of life measures(2 years)

研究者

发起方
Uppsala University
申办方类型
Other

相似试验

已完成
不适用
Secondary Prevention of Problems in Health Status in Patients With Chronic Obstructive Pulmonary Disease (COPD)Health StatusChronic Obstructive Pulmonary Disease
NCT00940355Radboud University Medical Center303
Unknown
不适用
Secondary Prevention of Dug-related Problems Through Digital HealthDrug-Related Problems
NCT04841863Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau200
已完成
不适用
Secondary prevention of problems in health status in patients with COPD by early detection, motivational intervention to engage in treatment by the patient and by individualized treatmentChronic Obstructive Pulmonary Disease (COPD), Health Status, Quality of Life, Intervention, Patient-tailored treatment, gezondheidstoestand, kwaliteit van leven, interventie, zorg op maat
NL-OMON24431PICASSO-Partners in Care SolutionsRadboud University Nijmegen Medical Centre, department of Medical Psychology and department of Pulmonary DiseasesSponsor / Initiator: Radboud University Nijmegen Medical Centre, Department of Medical Psychology & Department of Pulmonary Diseases, Postbus 66, Nijmeegsebaan 31, 6560 AB Groesbeek120
已完成
不适用
Assessing the Feasibility of a Prevention m-Health App Intervention for Informal Caregivers of OutpatientsTelemedicineCaregiversPressure Ulcer
NCT05030935University of Nicosia45
招募中
2 期
A phase 2 study, investigating prevention and treatment algorism of the skin toxicity related with Panitumumab treatment in patients with unresectable and/or metastatic CRC with KRAS wild type refractory to 5-FU containing chemotherapy
JPRN-UMIN000005862ational Cancer Center Hospital East40